Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news
Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news
Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news
Submitted by
admin
on November 23, 2016 - 12:05pm
Source:
Bizjournals.com
News Tags:
Biogen
Eli Lilly
Alzheimer's disease
solanezumab
Headline:
Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news
Do Not Allow Advertisers to Use My Personal information
